Heterozygous loss of function mutations in human PKARlA gene (PRKARlA) have been identified in patients with Carney complex (CNC), an autosomal dominant familial multiple neoplasia syndrome displaying different endocrine tumors, including adrenocortical tumors, GH-secreting pituitary tumors and thyroid adenomas. Although PRKARlA is encoded by a single gene, it is transcribed from at least two different promoters, adjacent to different first non-coding exons (1 a and 1 b), giving rise to alternately spliced transcripts coding for identical proteins. The separate regulation of the two distinct promoters and the presence of multiple alternatively spliced first exons suggest a complex mechanism of PRKARlA expression regulation. In order to investigate the relative expression of the two mRNA transcripts (1a and 1b) in human adult endocrine tissues involved in the determination of CNC phenotype, we selected 17 pituitary, 20 adrenal and seven thyroid tissues from tumoral and peri-tumoral lesion samples. Expression of the two transcripts was evaluated by semi-quantitative RT-PCR and real-time RT-PCR. This study first reports that human pituitary and thyroid tissues show a similar expression of the two transcripts, whereas in adrenal tissues transcript I b is the most abundant one.
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands / E. Peverelli, G. Mantovani, S. Bondioni, C. Pellegrini, S. Bosari, A.G. Lania, P. Beck-Peccoz, A. Spada. - In: MOLECULAR AND CELLULAR ENDOCRINOLOGY. - ISSN 0303-7207. - 30:1-2(2005), pp. 51-55.
Expression of the two alternatively spliced PRKAR1A RNAs in human endocrine glands
E. PeverelliPrimo
;G. MantovaniSecondo
;S. Bondioni;C. Pellegrini;S. Bosari;A.G. Lania;P. Beck-PeccozPenultimo
;A. SpadaUltimo
2005
Abstract
Heterozygous loss of function mutations in human PKARlA gene (PRKARlA) have been identified in patients with Carney complex (CNC), an autosomal dominant familial multiple neoplasia syndrome displaying different endocrine tumors, including adrenocortical tumors, GH-secreting pituitary tumors and thyroid adenomas. Although PRKARlA is encoded by a single gene, it is transcribed from at least two different promoters, adjacent to different first non-coding exons (1 a and 1 b), giving rise to alternately spliced transcripts coding for identical proteins. The separate regulation of the two distinct promoters and the presence of multiple alternatively spliced first exons suggest a complex mechanism of PRKARlA expression regulation. In order to investigate the relative expression of the two mRNA transcripts (1a and 1b) in human adult endocrine tissues involved in the determination of CNC phenotype, we selected 17 pituitary, 20 adrenal and seven thyroid tissues from tumoral and peri-tumoral lesion samples. Expression of the two transcripts was evaluated by semi-quantitative RT-PCR and real-time RT-PCR. This study first reports that human pituitary and thyroid tissues show a similar expression of the two transcripts, whereas in adrenal tissues transcript I b is the most abundant one.File | Dimensione | Formato | |
---|---|---|---|
1-s2.0-S0303720705001231-main.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
182.14 kB
Formato
Adobe PDF
|
182.14 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.